PurPoSe: Recent studies have demonstrated the functional heterogeneity of fibroblasts, particularly in terms of their activities during wound healing. Both location within the dermis and embryonic lineages 1 provide a means by which we may now identify the sub-populations of fibroblasts chiefly responsible for connective tissue deposition during scar formation in the dorsal dermis.
PurPoSe: Recent studies have demonstrated the functional heterogeneity of fibroblasts, particularly in terms of their activities during wound healing. Both location within the dermis and embryonic lineages 1 provide a means by which we may now identify the sub-populations of fibroblasts chiefly responsible for connective tissue deposition during scar formation in the dorsal dermis.
1,2 However, whether these findings translate to the ventral dermis have yet to be elucidated.
MethodS: Prrx1
Cre /Rosa26 mTmG mice, were used to trace two fibroblast lineages restricted to the ventral dermis. Fibroblasts of different embryonic lineages-based on Prrx1 expression-were isolated from ventral fetal and adult dermis at a series of time points, including the lategestational transition from scarless to scar-forming wound healing. ATAC-seq (Assay for Transposase-Accessible Chromatin with high throughput sequencing) was also performed in isolated pre-and post-gestational fibroblasts.
reSultS: Histological analysis revealed that the Prrx1-positive lineage contributed to the majority of connective tissue during scar formation. Flow cytometry demonstrated a shift in fibroblast sub-populations over the course of gestation. Differential patterns of chromatin accessibility shown by ATAC-seq further demonstrated the heterogeneic nature of fibroblasts within the ventral dermis at an epigenetic level. 
ConCluSionS

Effects of Topical Hyaluronic Acid Injection in Surgical Site
aureus).
1 In some cases, antibiotics are insufficient for the treatment of S. aureus infection. S. aureus produces hyaluronidase which degrades hyaluronic acid (HA) and is one of its virulence factors in wound infection.
2 HA prevents bacterial proliferation and has anti-inflammatory effects to promote wound healing.
3 Herein, we studied the effects of HA injection with systemic antibiotics treatment on SSI caused by S. aureus.
MaterialS and MethodS: A single 2x1cm
2 open wound was created on each dorsum of 40 Sprague-Dawley rats. The wound bed was stitched three times with 3-0 vicryl suture inoculated with S. aureus (2x10 8 CFU/ml) to induce SSI. 4 The test group was treated with 200μg/kg of HA(n=20) and the control group received a subcutaneous injection of normal saline (n=20) in the infected wound. All groups were then treated with intraperitoneal 30mg/kg injections of cefazolin. The stitches were removed two days after the procedure. The gross pathology and bacterial count were assessed at days 2, 4, 6 and 8 post-procedure. The histologic grading and inflammatory cytokines in wound were assessed at day 8 post-procedure. Histologic grading was from 0 to 3 (0: none, 1: minimal, 2: moderate, 3: marked) based on the proportion of each finding within the entire wound.
reSultS:
The HA group showed significant reduction in the wound area (wound area of day X/wound area of Day0x100) compared to the control group (day8, 26.54 ± 6.12% vs 50.59 ± 5.50%, respectively; p<0.001), which is an assessment of the gross pathology. The HA group showed also significantly superior wound healing to the control group on histological analysis, including assessment of abscess, necrosis, neutrophil infiltration, edema, fibroplasias (4.2 ± 1.2 vs 11.5 ± 2.1, p<0.001). The HA group was significantly lower than the control group on the levels of TNF-α (324.0 ± 134.0pg/ml vs 433.8 ± 119.9pg/ ml, respectively; p=0.01) and IL-1ß (329.8 ± 151.7pg/ml vs 481.7 ± 204.5pg/ml, respectively; p=0.011). In addition, the HA group showed significantly lower bacterial counts compared to the control group (day8, 4.66 ± 0.45logCFU/ml vs 5.35 ± 0.37logCFU/ml, p<0.001). 
ConCluSion
MaterialS and MethodS:
Two 6 mm, full-thickness, splinted excisional wounds were created on both sides of the dorsal midline of C57bl/6 mice, and inoculated with 25 microliters of 1.5 × 10 8 colony forming units (CFU)/mL methicillin-resistant Staphylococcus aureus (MRSA) per wound. Mice were treated with NTP for 10 minutes or 20 minutes, respectively, for a total of 3 treatments every other day for 7 days. Wounds were aseptically swabbed and plated onto trypticase soy agar pre-and post-NTP treatment to monitor interim bacterial reduction during the study period. On day 7, wound tissue was harvested and homogenized for quantitative analysis of CFU/gram tissue remaining. reSultS: After NTP treatment, there was no gross or histological evidence of residue, aberrant dermal architecture, or edema in any of the wounds or intact skin. Interim agar growth from pre-and post-NTP aseptic swabbing revealed one logarithmic reduction in bacterial load for the 20-minute group, which was subsequently confirmed with serial dilutions of full-thickness, homogenized wound tissue. Wounds inoculated with MRSA and treated with NTP for 20 minutes had a 90% reduction in MRSA CFUs/gram of homogenized tissue (p = 0.0441) compared to untreated wounds. Efficacy of 20 minutes NTP treatment was confirmed by lack of anti-staph ab staining on sectioned wounds.
ConCluSion:
Our novel non thermal plasma device effectively disinfects clinically infected wounds in an in vivo murine wound healing model, without any evidence of damage to the wound or surrounding tissues. Effective against pathogenic MRSA, Steri-lysis TM is an innovative, low cost, portable technology that could potentially
